Newton Charles W.

Director at KROS; Chief Financial Officer at LYEL

Sold, on record
$35k
Dollars the filings state
Form 4 sales
5
Latest Nov 17, 2026
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • KROSKeros Therapeutics, Inc.Director
  • LYELLyell Immunopharma, Inc.Chief Financial Officer

Sales by reason

3
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale LYELNo plan
    Aug 12, 2025 2025

    Sold 267 shares at $10.43 ($3k)

    Newton Charles W., Chief Financial Officer

    No 10b5-1 planSold 3% of holdings ($94k position)8,759 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LYELNo plan
    Aug 21, 2025 +9 days

    Sold 1,453 shares at $10.54 ($15k)

    Newton Charles W., Chief Financial Officer

    No 10b5-1 planSold 8.7% of holdings ($177k position)15,306 shares leftFiling

  3. 3 Form 144 notice KROSNotice
    Jun 11, 2026 +294 days

    Filed to sell 550 shares ($5k)

    Newton Charles W., Director

    10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 sale KROSRoutine
    Jun 11, 2026 same day

    Sold 550 shares at $10.04 ($6k)

    Newton Charles W., Director

    10b5-1 planSold 4.2% of holdings ($133k position)12,665 shares leftFirst sale on recordFollows a Form 144Filing

  5. 5 Form 144 notice KROSNotice
    Aug 18, 2026 +68 days

    Filed to sell 551 shares ($6k)

    Newton Charles W., Director

    10b5-1 planFiling

  6. 6 Form 4 sale KROSRoutine
    Aug 18, 2026 same day

    Sold 551 shares at $10.30 ($6k)

    Newton Charles W., Director

    10b5-1 planSold 4.4% of holdings ($130k position)12,114 shares leftFollows a Form 144Filing

  7. 7 Form 4 sale KROSRoutine
    Nov 17, 2026 +91 days

    Sold 551 shares at $10.85 ($6k)

    Newton Charles W., Director

    10b5-1 planSold 4.5% of holdings ($131k position)11,563 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Newton Charles W.
Source
Nov 17, 2026Nov 19, 2026KROSDirectorForm 4 sale551$6k4.5%RoutineSEC
Aug 18, 2026Aug 20, 2026KROSDirectorForm 4 sale551$6k4.4%RoutineSEC
Aug 18, 2026Aug 18, 2026KROSDirectorForm 144 notice551$6kNoticeSEC
Jun 11, 2026Jun 15, 2026KROSDirectorForm 4 sale550$6k4.2%RoutineSEC
Jun 11, 2026Jun 11, 2026KROSDirectorForm 144 notice550$5kNoticeSEC
Aug 21, 2025Aug 22, 2025LYELChief Financial OfficerForm 4 sale1,453$15k8.7%No planSEC
Aug 12, 2025Aug 13, 2025LYELChief Financial OfficerForm 4 sale267$3k3.0%No planSEC